NCT02922452View on ClinicalTrials.gov

A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Ischemic Stroke
Interventions
DRUG

BMS-986141

Single dose BMS-986141 and Multiple doses of Dilitazem

DRUG

Dilitazem

Single dose BMS-986141 and Multiple doses of Dilitazem

Trial Locations (1)

78744

PPD Development, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY